INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new ...
Zepbound (tirzepatide) is a brand-name injection doctors prescribe for weight loss, weight management, and more. It may take several months of using Zepbound before you see the drug’s full effects for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results